Spironolactone Tablet, Coated
Product Images NDC 68788-8452

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68788-8452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone Tab Usp 50mg (5e456f3c F93e 41c6 80c5 A737ed70feda 00)

Spironolactone Tab Usp 50mg (5e456f3c F93e 41c6 80c5 A737ed70feda 00)
Label for Spironolactone 50 mg coated tablets by Preferred Pharmaceuticals Inc. The label states the drug is generic for Aldactone and produced by Oxford Pharmaceuticals, LLC. It includes directions in English and Spanish for daily tablet intake, caution statements about storage and prescription use, and spaces for package size, lot number, and expiration date.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve showing probability over time in months for two groups: Spironolactone (n=822) with a dashed line, and Placebo (n=841) with a solid line. The y-axis represents probability, and the x-axis represents months, with a log-rank p value less than 0.001 indicated on the plot.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a clinical study. Subgroups include age, sex, race, LVEF, heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot compares Spironolactone and placebo effectiveness, with markers indicating HR values and confidence intervals for each subgroup.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure diagram of the active ingredient spironolactone, showing its molecular components and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.